GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Blum Holdings Inc (OTCPK:BLMH) » Definitions » Pre-Tax Income

BLMH (Blum Holdings) Pre-Tax Income : $4.20 Mil (TTM As of Sep. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Blum Holdings Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Blum Holdings's pretax income for the three months ended in Sep. 2024 was $-3.20 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was $4.20 Mil. Blum Holdings's pretax margin was -73.24%.

During the past 13 years, Blum Holdings's highest Pretax Margin was 51.45%. The lowest was -376.11%. And the median was -161.65%.


Blum Holdings Pre-Tax Income Historical Data

The historical data trend for Blum Holdings's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blum Holdings Pre-Tax Income Chart

Blum Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -38.99 -44.15 -8.01 -41.18 -195.63

Blum Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Jun24 Sep24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.07 -4.74 -3.56 7.39 -3.20

Competitive Comparison of Blum Holdings's Pre-Tax Income

For the Drug Manufacturers - Specialty & Generic subindustry, Blum Holdings's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blum Holdings's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Blum Holdings's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Blum Holdings's Pre-Tax Income falls into.



Blum Holdings Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Blum Holdings's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-37.259+-154.202+-4.173+0+2.8421709430404E-14
=-195.63

Blum Holdings's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.841+-0.69+-0.665+0+0
=-3.20

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blum Holdings  (OTCPK:BLMH) Pre-Tax Income Explanation

Blum Holdings's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-3.196/4.364
=-73.24%

During the past 13 years, Blum Holdings's highest Pretax Margin was 51.45%. The lowest was -376.11%. And the median was -161.65%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Blum Holdings Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Blum Holdings's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Blum Holdings Business Description

Traded in Other Exchanges
N/A
Address
3242 S. Halladay Street, Suite 202, Santa Ana, CA, USA, 92705
Blum Holdings Inc is a cannabis company with operations in retail, production, distribution, and cultivation, with an emphasis on providing the highest quality of medical and adult-use cannabis products. It distributes its own branded products as well as third-party products to its retail dispensaries in California under the Korova brand. The company has two reportable segments; Cannabis Retail which generates key revenue and includes cannabis-focused retail, both physical stores and non-store front delivery, and the Cannabis Distribution segment which includes cannabis distribution operations.
Executives
Patty Chan officer: CHIEF FINANCIAL OFFICER 11516 DOWNEY AVE, DOWNEY CA 90241
Oren Schauble officer: President 3242 S HALLADAY ST., SUITE 202, SANTA ANA CA 92705
Dallas Imbimbo director 1800 NEWPORT CIRCLE, SANTA ANA CA 92705
Eric Baum director 866 BERKSHIRE DRIVE, WESTBURY NY 11590
Tiffany N. Davis director 11852 MANHATTAN CT., RANCHO CUCAMONGA CA 91730
Michael Nahass director 2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Derek Peterson director, officer: President and CEO 2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Alan David Gladstone other: Former Director of Issuer P.O BOX 9699, NEWPORT BEACH CA 92658
Uri Kenig officer: Chief Operating Officer 2040 MAIN ST., SUITE 225, IRVINE CA 92614
Ira E. Ritter director C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Nicholas Kovacevich director 2618 SAN MIGUEL DRIVE, #480, NEWPORT BEACH CA 92660
Knuettel Ii Francis director 205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
Jeffrey Robert Batliner officer: Chief Financial Officer 2040 MAIN STREET, SUITE 225, IRVINE CA 92614
Megan Jimenez officer: Chief Financial Officer 2040 MAIN ST., SUITE 225, IRVINE CA 92614
Matthew Morgan director, officer: Chief Executive Officer 2040 MAIN STREET, SUITE 225, IRVINE CA 92614